The Cost of Mental Health Care: A Cost-Sharing Law

By Staff Writer

March 31, 2024

Introduction:

The scarcity of mental health and substance use disorder (MH/SUD) treatment is a significant public health issue in the US, contributing to high levels of morbidity and mortality. Many people with MH/SUDs often hesitate to seek health care due to stigma and the lack of accessible clinicians. For those with commercial insurance, out-of-pocket expenses due to cost-sharing serve as another barrier. This article examines the mental health landscape in the US and the impact of cost-sharing laws on the cost of healthcare, focusing on the New Mexico No Behavioural Health Cost Sharing (NCS) law.

Who Receives Mental Health Care?

Persistent disparities exist in access to mental health care. In 2021, only 47% of US adults with mental illness received any mental health services. Workforce shortages contribute to this issue, with more than half of US residents living in areas short of mental health professionals. Even insured individuals often find it difficult to use their insurance for care, as nearly half of psychiatrists do not accept insurance. In 2021, 55% of people with serious mental illness who needed but did not receive mental health care cited unaffordability as the main barrier. Inadequate insurance payment and coverage was the primary obstacle for an additional 33%.

Towards More Equitable Access

The tradition of private practice psychiatry, coupled with the availability of cash-paying patients, exacerbates mental health workforce shortages, especially when demand outstrips supply. Despite expansions in insurance coverage and legal mandates that health plans include mental health care coverage, out-of-pocket costs remain a significant barrier. In 2021, racial and ethnic disparities in treatment rates were also evident.

The Implications of Cost-Sharing

Cost-sharing, which includes copayments, coinsurance, and deductibles, is designed to curb the overuse of health care. However, for individuals with MH/SUDs, cost-sharing can discourage the use of effective treatments. The RAND Health Insurance experiment in the 1970s demonstrated this, showing that higher cost-sharing led to larger reductions in mental health care than other health care use.

The New Mexico No Behavioural Health Cost Sharing Law

In April 2021, New Mexico passed the NCS law, prohibiting cost-sharing for MH/SUD treatment for individuals with commercial insurance plans. This law was a response to the need to reduce the costs of MH/SUD treatment, given the vast personal and societal costs of these conditions. However, the impact of the law on patient outcomes is yet to be fully understood.

The Impact of the New Mexico No Behavioural Health Cost Sharing Law

In order to lower MH/SUD treatment costs, the NCS was passed. The NCS applies solely to state-regulated commercial insurance plans, including fully insured, employer-sponsored plans, individual market plans, and New Mexico state employee health plans (SEHPs), which cover public school employees. The data suggests that the NCS effectively shielded patients from out-of-pocket spending on medications for MH/SUDs. A recent study discovered that the average out-of-pocket expense for psychotropic medications decreased by $6.37, or 85.6%, when compared to New Mexico federal employees who were not impacted by NCS. However, the overall volume of dispensed MH/SUD prescription drugs did not significantly change.

Conclusion:

New Mexico’s NCS law provides a case study on how legislation can tackle financial obstacles to mental health care. It has effectively cut down out-of-pocket costs for psychotropic drugs. However, the total amount of dispensed MH/SUD prescription drugs hasn’t changed significantly. This situation highlights the complex nature of mental health care access. It’s not just about cost, but also about professional availability and lingering mental health stigma. We have yet to see the law’s effect on non-drug services. Yet, the initial success in lessening the financial strain of medication signals a hopeful beginning. Despite this, the data on mental health care access indicates a long road to equitable mental health care. It’s clear that while laws like NCS can contribute, we need a multi-faceted strategy. This strategy should address workforce shortages, insurance coverage, and societal stigma.

Reference url

Recent Posts

capivasertib cost-effectiveness
      

Capivasertib Cost-Effectiveness in Advanced Breast Cancer

💡What’s the strategy to bring capivasertib’s price within reach of breast cancer patients?

A recent study evaluates capivasertib, an AKT inhibitor, as a second-line treatment for advanced breast cancer, revealing that its costs significantly outweigh the added health benefits. The analysis indicates that to be cost-effective, a substantial reduction in its price is necessary.

Delve into the economic implications of this treatment and the pressing need for pricing reforms in healthcare.

#SyenzaNews #HealthEconomics #costeffectiveness #oncology

reserve antibiotics benefits
           

Reserve Antibiotics Benefits: G-BA Designates Meropenem/Vaborbactam as Critical Reserve Treatment

🔍 What makes reserve antibiotics crucial in the fight against antimicrobial resistance?

The recent assessment of Meropenem/Vaborbactam by the G-BA highlights its vital role as a reserve antibiotic for severe gram-negative infections, ensuring effective treatment options when others fail. With tight regulations and stewardship in place, its designation underscores the importance of preserving these powerful tools in modern medicine.

Dive into the article to explore the implications for healthcare, economics, and patient safety.

#SyenzaNews #HealthcareInnovation #HealthEconomics

robotic surgery approval
               

NICE Grants Conditional Robotic Surgery Approval to Enhance Patient Care and Address Health Inequities

🤖 Are you ready for the future of surgery?

The recent approval of 11 robotic surgery systems by NICE could improve patient care in the NHS, leading to faster recoveries and minimal invasiveness. With a focus on real-world evidence, this transformative step aims to improve health outcomes while addressing access and equity concerns.

Explore how this innovative approach will shape the landscape of surgical procedures in the coming years!

#SyenzaNews #HealthcareInnovation #MedicalDevices #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.